Starting My Career as a Cardiologist During COVID-19

por Giblett, Joel P.
Publicado 2020

Does Impella Support Really Prevent Catastrophe?

por Giblett, Joel P.
Publicado 2020

Cardioprotection for Acute MI in Light of the CONDI2/ERIC-PPCI Trial: New Targets Needed

por Giblett, Joel P, Bulluck, Heerajnarain
Publicado 2020

Iatrogenic Aortocoronary Dissection During Percutaneous Coronary Intervention: Investigation and Management

por Hung, John, Giblett, Joel P.
Publicado 2021

Are Vasopressors an Enemy of the Coronary Arteries?

por Rubini Gimenez, Maria, Giblett, Joel P.
Publicado 2019

Glucagon-Like Peptide-1: A Promising Agent for Cardioprotection During Myocardial Ischemia

por Giblett, Joel P., Clarke, Sophie J., Dutka, David P., Hoole, Stephen P.
Publicado 2016

Patent Foramen Ovale Closure in 2019

por Giblett, Joel P, Abdul-Samad, Omar, Shapiro, Leonard M, Rana, Bushra S, Calvert, Patrick A
Publicado 2019

Patent Foramen Ovale Closure: State of the Art

por Giblett, Joel P, Williams, Lynne K, Kyranis, Stephen, Shapiro, Leonard M, Calvert, Patrick A
Publicado 2020

A Giant Saphenous Vein Graft Aneurysm Treated With Percutaneous Closure

por Klementowicz, Pawel, Giblett, Joel P., Agrawal, Sanjay K.B., Shapiro, Leonard M., Calvert, Patrick A.
Publicado 2019

Percutaneous Transcatheter Closure of Post-infarction Ventricular Septal Defect: An Alternative to Surgical Intervention

por Cadogan, Diarmaid, Daghem, Marwa, Snosi, Mostafa, Williams, Lynne K, Weir-McCall, Jonathan, Calvert, Patrick A, Giblett, Joel P
Publicado 2023

Impact of percutaneous patent foramen ovale closure on migraine headaches in patients with history of ischemic neurological events

por Węglarz, Przemysław, Spisak-Borowska, Katarzyna, Bochenek, Tomasz, Konarska-Kuszewska, Ewa, Machowski, Jerzy, Trusz-Gluza, Maria, Bajor, Grzegorz, Mizia-Stec, Katarzyna, Giblett, Joel P., Calvert, Patrick A.
Publicado 2020

Glucagon-Like Peptide-1–Mediated Cardioprotection Does Not Reduce Right Ventricular Stunning and Cumulative Ischemic Dysfunction After Coronary Balloon Occlusion

por Giblett, Joel P., Axell, Richard G., White, Paul A., Aetesam-Ur-Rahman, Muhammad, Clarke, Sophie J., Figg, Nicola, Bennett, Martin R., West, Nick E.J., Hoole, Stephen P.
Publicado 2019

Stunning and Right Ventricular Dysfunction Is Induced by Coronary Balloon Occlusion and Rapid Pacing in Humans: Insights From Right Ventricular Conductance Catheter Studies

por Axell, Richard G., Giblett, Joel P., White, Paul A., Klein, Andrew, Hampton‐Til, James, O'Sullivan, Michael, Braganza, Denise, Davies, William R., West, Nick E. J., Densem, Cameron G., Hoole, Stephen P.
Publicado 2017

GLP-1 vasodilatation in humans with coronary artery disease is not adenosine mediated

por Aetesam-ur-Rahman, Muhammad, Giblett, Joel P., Khialani, Bharat, Kyranis, Stephen, Clarke, Sophie J., Zhao, Tian X., Braganza, Denise M., Clarke, Sarah C., West, Nick E. J., Bennett, Martin R., Hoole, Stephen P.
Publicado 2021

Adenosine‐Induced Coronary Steal Is Observed in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction

por Aetesam‐ur‐Rahman, Muhammad, Brown, Adam J., Jaworski, Catherine, Giblett, Joel P., Zhao, Tian X., Braganza, Denise M., Clarke, Sarah C., Agrawal, Bobby S. K., Bennett, Martin R., West, Nick E. J., Hoole, Stephen P.
Publicado 2021

Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies

por Giblett, Joel P., Axell, Richard G., White, Paul A., Clarke, Sophie J., McCormick, Liam, Read, Philip A., Reinhold, Johannes, Brown, Adam J., O’Sullivan, Michael, West, Nick E. J., Dutka, David P., Hoole, Stephen P.
Publicado 2016

GLP‐1 Is a Coronary Artery Vasodilator in Humans

por Clarke, Sophie J., Giblett, Joel P., Yang, Lucy L., Hubsch, Annette, Zhao, Tian, Aetesam‐ur‐Rahman, Muhammad, West, Nick E. J., O'Sullivan, Michael, Figg, Nichola, Bennett, Martin, Wewer Albrechtsen, Nicolai J., Deacon, Carolyn F., Cheriyan, Joseph, Hoole, Stephen P.
Publicado 2018